New guidance advises health professionals on how to communicate the results of invasive cancer audit reviews to women who were previously screened in the NHS cervical screening programme.
Head of screening quality assurance, Screening Quality Assurance Service (Midlands & East) Public Health England
PHE Screening is delighted to publish its first annual data report on the national cervical screening programme standards, focusing on performance in England from 1 April 2018 to 31 March 2019.
In March 2019, Public Health England launched the first ever national cervical screening campaign, Cervical Screening Saves Lives. With an evaluation under way, now is a good time to share some of the highlights from the campaign, along with some early signs of its impact.
PHE has published guidance describing the role and responsibilities of cervical screening provider leads.
For the first time ever, we’re publishing detailed cervical screening coverage data by GP practice. Coverage is the proportion of women eligible for screening who have a test result recorded in the last 3 or 5 years, depending on their age.
The breast, bowel and cervical screening programmes require consultant pathologists and other specialist laboratory staff to take part in ‘external quality assessment’ or EQA. But what is EQA exactly?
Related content and links
The PHE Screening team
Public Health England (PHE) existed to protect and improve the nation’s health and wellbeing, and reduce health inequalities. It closed on 30 September 2021 and this blog is no longer updated.
Find out more about the implications for health screening in our Changes ahead for the national screening system blog article.
If you want to stay in touch with screening evidence and policy news, you can subscribe to the UK National Screening Committee blog.
Comments and moderation
- Changes ahead for the national screening system 30 September 2021
- What we blogged about in August and September 2021 30 September 2021
- New resources to help improve quality of samples taken in NHS newborn blood spot screening 30 September 2021